We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$421M
AUM Growth
-$97M
Cap. Flow
-$103M
Cap. Flow %
-24.48%
Top 10 Hldgs %
40.42%
Holding
78
New
4
Increased
9
Reduced
51
Closed
7

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$11.4M
2
PEP icon
PepsiCo
PEP
+$6.17M
3
NVS icon
Novartis
NVS
+$6.03M
4
BTI icon
British American Tobacco
BTI
+$4.75M
5
NVO
Novo Nordisk
NVO
+$3.41M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$26.3M
2
MSFT icon
Microsoft
MSFT
+$6.91M
3
BG icon
Bunge Global
BG
+$5.72M
4
MDT icon
Medtronic
MDT
+$5.28M
5
UNP icon
Union Pacific
UNP
+$4.97M

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Technology 15.78%
3 Industrials 13.89%
4 Financials 12.97%
5 Consumer Staples 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHI
26
DELISTED
Baker Hughes
BHI
$6.48M 1.54%
99,794
-201
-0.2% -$11.9K
CCU icon
27
Compañía de Cervecerías Unidas
CCU
$2.17B
$5.67M 1.35%
270,034
-5,174
-2% -$106K
CHRW icon
28
C.H. Robinson
CHRW
$20.7B
$4.98M 1.18%
67,921
+15,407
+29% +$1.11M
BTI icon
29
British American Tobacco
BTI
$131B
$4.72M 1.12%
+83,820
New +$4.75M
MRK icon
30
Merck
MRK
$325B
$4.63M 1.1%
82,379
-38,913
-32% -$2.28M
BG icon
31
Bunge Global
BG
$22.8B
$4.15M 0.99%
57,443
-85,803
-60% -$5.72M
OUT icon
32
Outfront Media
OUT
$5.7B
$4.11M 0.98%
167,877
-51
-0% -$1.17K
HOG icon
33
Harley-Davidson
HOG
$2.63B
$4.04M 0.96%
69,298
+5
+0% +$285
KO icon
34
Coca-Cola
KO
$360B
$3.89M 0.92%
93,720
– –
PTR
35
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$3.88M 0.92%
52,696
-12,798
-20% -$903K
HSY icon
36
Hershey
HSY
$36.1B
$3.85M 0.91%
37,186
+12,486
+51% +$1.23M
CAH icon
37
Cardinal Health
CAH
$53.9B
$3.71M 0.88%
51,580
-44,688
-46% -$3.23M
MTB icon
38
M&T Bank
MTB
$36.1B
$3.7M 0.88%
23,658
-5,503
-19% -$745K
TUP
39
DELISTED
Tupperware Brands Corporation
TUP
$3.56M 0.85%
67,633
-54,411
-45% -$3.19M
RDS.A
40
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.54M 0.84%
65,090
-2,373
-4% -$122K
SWK icon
41
Stanley Black & Decker
SWK
$14.4B
$3.45M 0.82%
30,089
-3,577
-11% -$426K
NVO
42
Novo Nordisk
NVO
$219B
$3.37M 0.8%
+188,114
New +$3.41M
EMR icon
43
Emerson Electric
EMR
$82.5B
$3.31M 0.79%
59,390
-75,007
-56% -$4.03M
KT icon
44
KT
KT
$8.91B
$3.13M 0.74%
221,903
-10,079
-4% -$152K
MAT icon
45
Mattel
MAT
$4.26B
$3.09M 0.73%
112,129
-93,638
-46% -$2.85M
UL icon
46
Unilever
UL
$132B
$3.06M 0.73%
+66,721
New +$3.11M
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.66M 0.63%
16,323
– –
IBN icon
48
ICICI Bank
IBN
$107B
$2.62M 0.62%
384,577
-17,870
-4% -$127K
PX
49
DELISTED
Praxair Inc
PX
$2.5M 0.59%
21,307
+217
+1% +$25.8K
MDLZ icon
50
Mondelez International
MDLZ
$77.8B
$2.45M 0.58%
55,256
– –
1
2
3 4

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q4 2016 Portfolio in Review

As of Q4 2016, Foyston, Gordon, & Payne held 78 positions worth $421M, down 19% from $518M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $103M in Q4 2016, closing 7 positions and reducing 51 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in British American Tobacco worth $4.72M.

  • Foyston, Gordon, & Payne's largest Q4 2016 buy was British American Tobacco: 83,820 shares worth $4.72M.
  • Foyston, Gordon, & Payne added most to Aon in Q4 2016, an estimated $11.4M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2016 reduction was Microsoft, cutting an estimated $6.91M.
  • Foyston, Gordon, & Payne fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $26.3M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 40% of its $421M portfolio in Q4 2016.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 7 in Q4 2016.
  • Foyston, Gordon, & Payne's portfolio value fell 19% quarter-over-quarter to $421M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2016, filed 13 Feb 2017.